Navigation Links
Let Blind Eyes Be Opened - Stem Cell Therapy and Aniridia

British scientists offer a ray of hope to persons suffering from aniridia - a rare defect of being born with no iris.//

Around 1,000 people in the UK alone, suffer from this rare genetic disorder, aniridia, which means they are born without the stem cells that can rejuvenate tissue in the eye.

Sufferers develop diseases normally associated with old age - such as glaucoma or cataracts - when they are young.

Aniridia results in near blindness since the limbal cells that keep the surface of the cornea clear and healthy are missing or few in number.

The revolutionary treatment to restore sight caused by the absence of an iris is being carried out by Dr. Sheraz Daya of Queen Victoria Hospital in East Grinstead, West Sussex, after 7 years of perfecting the technique. This is carried out by using stem cell therapy.

In the procedure, stem cells are harvested from live or dead donors, or the patients themselves, and cultivated in lab dishes.

Once they attain a sheet like growth, they are transplanted into the cornea of the patient and held down with amniotic membranes sourced from donated placentas. The membrane dissolves within 2 to 3 weeks and within a few months the stem cells trigger the complete growth of the epithelium, or top layer of the cornea. They themselves disappear then ,thus eliminating the need of immuno-suppressant drugs.

So far Daya has carried out four such procedures successfully.

Says Daya: "We think the donor cells have attracted stem cells from the bone marrow to make new limbal stem cells, which have arrived at the eye through the bloodstream.

"Once we understand what has prompted their growth, then we can understand what they can do for other parts of the body", he adds.

Similar transplants have been carried out in Japan, the US, Italy and Taiwan, but this is the first time they have been used for patients with aniridia.
ANN
'"/>




Page: 1

Related medicine news :

1. Blindness can be stopped with drug for acne treatment
2. Smoking Linked to Blindness
3. Blindness may be genetic by nature
4. Enzyme Responsible For Congenital Blindness
5. Smokers Face The Risk Of Becoming Blind In Later Life
6. Millions Of Diabetic And Glaucoma Patients Risk Blindness
7. See Me Campaign: Do Not Turn a Blind Eye and a Deaf Ear to Self-Harm
8. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
9. Genes That Were Responsible For The Cause Of Blindness Identified
10. Investigations Reveal That Infections Due To Contact lens Could Cause Blindness
11. Blind Girl Students to Catwalk in Guwahati Fashion Show
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Let Blind Eyes Opened Stem Cell Therapy and Aniridia

(Date:5/24/2013)... 25, 2013 Part guidebook, part memoir, ... a tried and true approach to meditation for the ... Mastering the 11th Step, the book outlines a comprehensive ... of the 11th step in any 12-step recovery programs ... drug dependence an ever-growing global health problem affecting the ...
(Date:5/24/2013)... 2013 Range Kleen Mfg. strives to “TCOTC.” ... Customer, from the President's desk to the Shipping Dock.” We ... integrity, and having passion while creating excellence and quality being ... company to do the right thing and what better way ... affected by devastation. , Throughout the year Range Kleen donates ...
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... from the 2010 DePuy hip recall continue to move ... reports. According to documents filed in California’s San ... had been seeking an expedited trial of her DePuy ... (Tilman v. DePuy Orthopaedics, Inc., et al., No. ...
(Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...
(Date:5/24/2013)... research suggests a link between sleep duration and ... additional hour someone with insomnia sleeps is associated ... of moderate or high risk of suicide, according ... "We were surprised by the strength of ... study author, Linden Oliver, clinical research coordinator for ...
Breaking Medicine News(10 mins):Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 2Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 3Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2
... the continued presence of a doula an experienced non-medical ... beneficial effects for middle- and upper-class women in childbirth, even ... with them, according to a new study in the journal ... of 420 pregnant women in their third trimester were randomized ...
... CHESTNUT HILL, MA A critical enzyme used to ... help drug makers better target the cells the natural ... 23 edition of the Journal of Biological Chemistry. , ... of researchers from Boston College and the University of ...
... WILMINGTON, Del., May 29 AARP announced today ... reveals concerns,regarding health care access and affordability. AARP presented ... needs and disparities in,Delaware. View Delaware Health Care: A ... ., The key survey findings show that controlling ...
... 29 PartnerRe Ltd.,(NYSE: PRE ) today announced ... is scheduled to present at the Fox,Pitt-Kelton Cochran Caronia ... for the Insurers... and the Contrast with,Banks." The half-day ... 2008 from 9 a.m. - 2 p.m. local time ...
... N.C., May 29 Quality projects are not ... not,breakthroughs. However, these increments can grow to be ... had median savings of $1.2,million from their largest-impact ... complimentary excerpt "Transforming the Supply Chain: The,Impact of ...
... 60 Different Medical and Aesthetic ... ... Ltd. ("Alma Lasers"), a,global developer and marketer of laser, light, and ... clearance,for its Harmony(XL), the newest platform for multiple aesthetic laser and,light ...
Cached Medicine News:Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2Health News:AARP Survey Reveals Boomers' Health Care Needs in Delaware 2Health News:AARP Survey Reveals Boomers' Health Care Needs in Delaware 3Health News:PartnerRe Executive Vice President & Chief Financial Officer Albert Benchimol to Present at the FPK CCW Credit Risk Conference in London on June 6, 2008 2Health News:Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008 2
(Date:5/23/2013)... de mayo de 2013  Volcano Corporation (NASDAQ: ... fabricante de herramientas de precisión para terapia guiadas ... la enfermedad vascular periférica y coronaria, anunció hoy ... enosine V asodilator I ndependent ... sesión de ensayo clínico hot line late breaking ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... WILMINGTON, Del. , April 30 ... and Drug Administration (FDA) has approved VIMOVO™ ... of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ... gastric ulcers in patients at risk of developing NSAID-associated ...
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
Cached Medicine Technology:FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 2FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 3FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 4FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 5FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 6FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 7FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 8FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 9BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3
... Diagnostics Histoplasma DxSelect is intended for qualitatively ... in human serum. The test is indicated ... disease, as an aid in the presumptive ... is not intended for self-testing, and this ...
... Indirect immunofluorescent antibody (IFA) ... and semi-quantitation of human ... Epstein-Barr viral capsid antigen ... ten 12-well slides, FITC ...
... portable, battery-powered, micro-controlled, noninvasive bone growth stimulator ... primary lumbar spinal fusion surgery for one ... been shown in pre-clinical studies to help ... Clinical studies have also shown that individuals ...
... Medical Solutions introduces its new multifunctional ... with intuitive patient data management is ... and urological table. Lithoskop is an ... that covers all applications like lithotripsy, ...
Medicine Products: